Results 101 to 110 of about 33,608 (178)

Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases. [PDF]

PLoS Negl Trop Dis, 2021
Tonacio AC, do Nascimento Pedrosa T, Borba EF, Aikawa NE, Pasoto SG, Filho JCRF, Sampaio Barros MM, Leon EP, Lombardi SCFS, Junior AM, Azevedo AS, Schwarcz WD, Fuller R, Yuki EFN, Ugolini Lopes MR, Rodrigues Pereira RM, Sampaio Barros PD, de Andrade DCO, de Medeiros-Ribeiro AC, de Moraes JCB, Shinjo SK, Miossi R, da Silva Duarte AJ, Lopes MH, Kallás EG, Almeida da Silva CA, Bonfá E.   +26 more
europepmc   +1 more source

Public health role for fractional dosage of yellow fever vaccine. [PDF]

Lancet, 2021
Staples JE, Alvarez AR.
europepmc   +1 more source

Low-Dose Yellow Fever Vaccine in Adults in Africa. [PDF]

N Engl J Med
Kimathi D, Juan-Giner A, Bob NS, Orindi B, Namulwana ML, Diatta A, Cheruiyot S, Fall G, Dia M, Hamaluba MM, Nyehangane D, Karanja HK, Gitonga JN, Mugo D, Omuoyo DO, Hussein M, Oloo E, Kamau N, Wafula J, Bendera J, Silvester N, Mwavita J, Joshua M, Mwendwa J, Agababyona C, Ngetsa C, Aisha N, Moki F, Buluku T, Munene M, Mwanga-Amumpaire J, Lutwama J, Kayiwa J, Kamaara E, Barrett AD, Kaleebu P, Bejon P, Sall AA, Grais RF, Warimwe GM, NIFTY Investigators.   +40 more
europepmc   +1 more source

A Single Dose of Yellow Fever Vaccine Provides Long-Term Immunity in Japanese Travelers. [PDF]

Vaccines (Basel)
Fukushima S, Lim CK, Hamada A.
europepmc   +1 more source

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial. [PDF]

Lancet Infect Dis, 2023
Kimathi D, Juan-Giner A, Orindi B, Grantz KH, Bob NS, Cheruiyot S, Hamaluba M, Kamau N, Fall G, Dia M, Mosobo M, Moki F, Kiogora K, Chirro O, Thiong'o A, Mwendwa J, Guantai A, Karanja HK, Gitonga J, Mugo D, Ramko K, Faye O, Sanders EJ, Grais RF, Bejon P, Warimwe GM.   +25 more
europepmc   +1 more source

Safety and Immunogenicity of the Attenuated Yellow Fever Vaccine in Several Neotropical Primate Species. [PDF]

Vaccines (Basel)
Paula NF, Vieira AD, Santos DOD, Souza LDR, Coelho CM, Tinoco HP, Lima PCS, Motta ROC, Pereira VDS, Carvalho MPN, Fernandes CB, Azevedo AS, Arruda MS, Costa TA, Drumond BP, Leme FOP, Freire MDS, Paixão TAD, Oliveira AR, Santos RL.   +19 more
europepmc   +1 more source

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study. [PDF]

Trials, 2022
Mackenzie GA, Osei I, Salaudeen R, Secka O, D'Alessandro U, Clarke E, Schmidt-Chanasit J, Licciardi PV, Nguyen C, Greenwood B, Mulholland K.   +10 more
europepmc   +1 more source

Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to standard dose in children 9-23 months old in Uganda, 2019-2022 - final report. [PDF]

Vaccine
Lee SE, Najjengo M, Shaum A, Sekiziyivu AB, Carlock G, Casey RM, Lubega I, Tumwine C, Twinomuhwezi-Oyet E, Nakato WN, Sciarratta CN, Hyde TB, Chu SY, Doshi RH, Kambugu A, Gidudu JF.   +15 more
europepmc   +1 more source

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease. [PDF]

J Bras Nefrol
Distenhreft JIQ, Couto-Lima D, Andreazzi CS, Thomazini JFRC, Vasconcellos Filho LM, Falqueto A, Luchi WM.   +6 more
europepmc   +1 more source

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial. [PDF]

PLoS Negl Trop Dis, 2023
Sandberg JT, Löfling M, Varnaitė R, Emgård J, Al-Tawil N, Lindquist L, Gredmark-Russ S, Klingström J, Loré K, Blom K, Ljunggren HG.   +10 more
europepmc   +1 more source